COVID-19 Sample Collection Kits; Accurate and Reliable Test for Diagnosing COVID-19
COVID-19 Sample Collection Kits |
The COVID-19 sample collection kits are used to diagnose and
detect COVID-19, an infectious disease caused by the SARS-CoV-2 virus. It is the most critical step in the effective diagnosis
of active infection. COVID-19 sample collection kits comprises the critical
reagents provided for collecting the samples and delivering them to the
laboratory to diagnose and detect SARS-CoV2 virus infection. Different
types of kits are available to diagnose COVID-19, such as swab collection kit
for RT-PCR test and rapid antigen test.
The swabs are available in
various packaging formats, from bulk packs ideal for diagnostic kit assembly,
to single swab peel-packs ideal for POC (Point of Care) testing. The contents
of this kit are to be used for the qualitative detection of SARS-CoV-2 antigen
from nasal swab. Other specimen types may lead to incorrect results and must
not be used. The nose swab PCR test for COVID-19 is an accurate and reliable
test for diagnosing COVID-19. Get tested if you have symptoms of COVID-19 or
have been exposed to someone who tested positive.
The Global
COVID-19 Sample Collection Kits Market is estimated to be valued
at US$ 12.0 billion in 2021 and expected to exhibit a CAGR of 4.1% during the
forecast period (2021-2028).
Rapid diagnostic test (RDT)
of a sample of the respiratory tract of a person helps to detect the viral
proteins (antigens) related to COVID-19. Along with laboratory tests, chest CT
scans may be helpful to diagnose COVID-19 infection. Thus, with the increase in
number of COVID-19 cases, the demand for COVID-19 sample collection kits
is also increasing. According to the World Health Organization (WHO), there
have been 81,824,843 confirmed cases of COVID-19 in the U.S., from 3 January
2020 to 18 May 2022, with 992,667 deaths.
Since the start of the
pandemic, the Food and Drug Administration (FDA) has authorized more than 400
tests and collection kits, including 235 molecular tests, 88 antibody tests,
& 34 antigen tests. The FDA is
committed to helping ensure the public has access to a wide variety of test
options for COVID-19.
Comments
Post a Comment